A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach.

Francesco LanzaFrancesco SaraceniAnnalisa PezziMassimo MartinoAlberto BosiNicola CascavillaPellegrino MustoEliana ZuffaMonica TaniClaudia CelliniDaniele LaszloFrancesca Bonifazinull null

Published in: American journal of hematology (2017)

Keyphrases

stem cells
multiple myeloma
diffuse large b cell lymphoma
magnetic resonance
contrast enhanced
network analysis
cross sectional
double blind
cell therapy
chemotherapy induced
magnetic resonance imaging
bone marrow
mesenchymal stem cells